How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

687 results for

Cardiovascular rehabilitation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Inclusion of stroke in cardiovascular risk prediction instruments

Inclusion of stroke in cardiovascular risk prediction instruments AHA/ASA Scientific Statement Inclusion of Stroke in Cardiovascular Risk Prediction Instruments A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Daniel T. Lackland, DrPH, FAHA, Co-Chair; Mitchell S.V. Elkind, MD, MS, FAAN, FAHA, Co-Chair; Ralph D’Agostino, Sr, MD (...) on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, and Council on Quality of Care and Outcomes Research Background and Purpose—Current US guideline statements regarding primary and secondary cardiovascular risk predictionandpreventionuseabsoluteriskestimatestoidentifypatientswhoareathighriskforvasculardiseaseevents and who may benefit from specific preventive interventions. These guidelines do not explicitly include patients with stroke

2012 American Academy of Neurology

82. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models

Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February (...) 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models A Scientific Statement From the American Heart Association , MD, MPH, FAHA , MD, FAHA

2012 American Heart Association

83. Sexual Activity and Cardiovascular Disease

, excessive dyspnea, ischemic ST-segment changes, cyanosis, hypotension, or arrhythmia (Class IIa; Level of Evidence C) . Cardiac rehabilitation and regular exercise can be useful to reduce the risk of cardiovascular complications with sexual activity for patients with CVD (Class IIa; Level of Evidence B) . , Patients with unstable, decompensated, and/or severe symptomatic CVD should defer sexual activity until their condition is stabilized and optimally managed (Class III; Level of Evidence C) . Patients (...) ), sexual activity should be deferred until the patient is stabilized and optimally managed. In patients whose exercise capacity or cardiovascular risk is unknown, exercise stress testing can be useful to assess exercise capacity and development of symptoms, ischemia, cyanosis, hypotension, or arrhythmias. Exercise training during cardiac rehabilitation has been shown to increase maximum exercise capacity and decrease peak coital heart rate. Regular exercise is associated with a decreased risk of sexual

2012 American Heart Association

84. Cardiovascular disease prevention

Cardiovascular disease prevention Cardio Cardiovascular disease pre vascular disease prev vention ention Public health guideline Published: 22 June 2010 nice.org.uk/guidance/ph25 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Cardiovascular disease prevention (PH25) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 113Contents Contents Overview 5 Who is it for? 5 Introduction 6 1 Recommendations 7 Recommendations

2010 National Institute for Health and Clinical Excellence - Clinical Guidelines

85. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs 2010 Update: Heart Failure in Ethnic Minority Populations, Heart Failure and Pregnancy, Disease Management, and Quality Improvement/Assurance Programs Disclosures of Conflict of Interests Page 1 Member Has an affiliation with commercial organizations (...) by CIHR but supported as well by an unrestricted gift to the Toronto Rehabilitation Institute(with which I am not affiliated) by Philips Respironics Inc None None None Nadia Giannetti No Servier, Novartis, Astellas None Novartis, Servier, AMgen None None None disclosed Adam Grzeslo None disclosed Primary Panel 2010 Update: Heart Failure in Ethnic Minority Populations, Heart Failure and Pregnancy, Disease Management, and Quality Improvement/Assurance Programs Disclosures of Conflict of Interests Page 2

2010 CPG Infobase

86. Cardiovascular Disease Prevention in Women: Evidence-Based Guidelines For

Cardiovascular Disease Prevention in Women: Evidence-Based Guidelines For PRACTICE GUIDELINE Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update A Guideline From the American Heart Association EXECUTIVE WRITING COMMITTEE Lori Mosca, MD, MPH, PhD, FAHA, Chair; Emelia J. Benjamin, MD, ScM, FAHA; Kathy Berra, MSN, NP; Judy L. Bezanson, DSN, CNS, RN; Rowena J. Dolor, MD, MHS; Donald M. Lloyd-Jones, MD, ScM; L. Kristin Newby, MD, MHS; Ileana L. Piña, MD (...) of Black Cardiologists (E.O.), National Institutes of Health Of?ce of Research on Women’s Health (V.W.P.), American College of Physicians† (K.S.), World Heart Federation (S.C.S.), and National Heart, Lung, and Blood Institute (G.S.). The following American Heart Association councils were also cosponsors: Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Basic Cardiovascular Sciences; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council

2011 American College of Cardiology

87. Management of Stroke Rehabilitation

Management of Stroke Rehabilitation VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF STROKE REHABILITATION Department of Veterans Affairs Department of Defense And The American Hea rt Association/ American Stroke Association Prepared by: THE MANAGEMENT OF STROKE REHABILITATION Working Group With support from: The Office of Quality and Performance, VA, Washington, DC & Quality Management Division, United States Army MEDCOM QUALIFYING STATEMENTS The Department of Veterans Affairs (VA (...) , and limitations unique to an institution or type of practice. Every healthcare professional making use of these guidelines is responsible for evaluating the appropriateness of applying them in any particular clinical situation. Version 2.0 2010 TABLE OF CONTENTS INTRODUCTION 2 Guideline Update Working Group Participants 7 Key Points 8 Outcome Measures 8 THE PROVISION OF REHABILITATION CARE Algorithm 12 Annotations 15 Rehabilitation Interventions 69 APPENDICES Appendix A: Guideline Development Process 112

2010 VA/DoD Clinical Practice Guidelines

88. Canadian Cardiovascular Society consensus conference update on cardiac transplantation

Canadian Cardiovascular Society consensus conference update on cardiac transplantation Can J Cardiol Vol 25 No 4 April 2009 197 Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary Primary Panel: H Haddad MD (Chair) 1 , D Isaac MD (Co-Chair) 2 , JF Legare MD 3 , P Pflugfelder MD 4 , P Hendry MD 1 , M Chan MD 5 , B Cantin MD 6 , N Giannetti MD 7 , S Zieroth MD 8 , M White MD 9 Secondary Panel: W Warnica MD 2 , K Doucette MD 5 , V Rao MD (...) Authority Cardiac Sciences Program, Winnipeg, Manitoba; 9 Montreal Heart Institute, Montreal, Quebec; 10 University of Toronto, Toronto, Ontario Correspondence: Dr Haissam Haddad, University of Ottawa Heart Institute, 40 Ruskin Street, Room 145, Ottawa, Ontario K1Y 4W7. Telephone 613-761-5165, fax 613-761-5212, e-mail hhaddad@ottawaheart.ca Received for publication December 17, 2008. Accepted December 21, 2008 T he Canadian Cardiovascular Society published its Consensus Conference on cardiac

2008 CPG Infobase

89. Cardiovascular Risk in Asymptomatic Adults: Guideline For Assessment of

Cardiovascular Risk in Asymptomatic Adults: Guideline For Assessment of PRACTICE GUIDELINES 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography (...) and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Writing Committee Members Philip Greenland, MD, FACC, FAHA, Chair Joseph S. Alpert, MD, FACC, FAHA George A. Beller, MD, MACC, FAHA Emelia J. Benjamin, MD, SCM, FACC, FAHA*† Matthew J. Budoff, MD, FACC, FAHA‡§ Zahi A. Fayad, PHD, FACC, FAHA¶ Elyse Foster, MD, FACC, FAHA# Mark. A. Hlatky, MD, FACC, FAHA§** John McB. Hodgson, MD, FACC, FAHA, FSCAI‡§**†† Frederick G. Kushner, MD, FACC, FAHA

2010 American College of Cardiology

90. Clinical Practice Guidelines for Endovascular Abdominal Aortic Aneurysm Repair: Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular and Interventional Radiological Society of Europe

Clinical Practice Guidelines for Endovascular Abdominal Aortic Aneurysm Repair: Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular and Interventional Radiological Society of Europe Clinical Practice Guidelines for Endovascular Abdominal Aortic Aneurysm Repair: Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular and Interventional Radiological (...) , there were reductions in the cardiovascular sup- port required during and after sur- gery, postoperative hospital stay, intensive care unit stay, and postoper- ative mortality and morbidity (78). Choice of anesthesia must be tailored totheindividualpatient,andwilltyp- ically vary by operator and by institu- tion. Table 6 Proximal Aortic Neck Calcification or Thrombus Scoring Grade Aortic Neck Diameter 0 Calcification 25% of circumference; atheroma or thrombus ( 2 mm thick) 25% of circumference 1

2010 Society of Interventional Radiology

91. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

for acute ischaemic and haemorrhagic stroke. [2] An acute stroke unit is a discrete area in the hospital that is staffed by a specialist stroke multidisciplinary team. It has access to equipment for monitoring and rehabilitating patients. Regular multidisciplinary team meetings occur for goal setting. [3] The committee felt that 'immediately' is defined as 'ideally the next slot and definitely within 1 hour, whichever is sooner' . [4] See NHS Data Dictionary, Critical care level. [5] In accordance

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

92. Chronic obstructive pulmonary disease in over 16s: diagnosis and management

of: • a history of cardiovascular disease, hypertension or hypoxia or or • clinical signs such as tachycardia, oedema, cyanosis or features of cor pulmonale Echocardiogram T o assess cardiac status if cardiac disease or pulmonary hypertension are suspected CT scan of the thorax T o investigate symptoms that seem disproportionate to the spirometric impairment T o investigate signs that may suggest another lung diagnosis (such as fibrosis or bronchiectasis) T o investigate abnormalities seen on a chest X-ray T (...) early intervention Assessment for pulmonary rehabilitation Identify candidates for pulmonary rehabilitation Assessment for a lung volume reduction procedure Identify candidates for surgical or bronchoscopic lung volume reduction Assessment for lung transplantation Identify candidates for surgery Dysfunctional breathing Confirm diagnosis, optimise pharmacotherapy and access other therapists Onset of symptoms under 40 years or a family history of alpha-1 antitrypsin deficiency Identify alpha-1

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

93. Hearing loss in adults: assessment and management

weeks after the hearing aids are fitted, with the option to attend this appointment by telephone or electronic communication if the person prefers. 1.7.2 At the follow-up audiology appointment for adults with hearing aids: ask the person if they have any concerns or questions address any difficulties with inserting, removing or maintaining their hearing aids provide information on communication, social care or rehabilitation support services if needed tell the person how to contact audiology (...) such as cardiovascular disease. Hearing loss may cause dementia either directly (for example, neuroplastic changes caused by hearing deprivation or increased listening demands) or indirectly via social isolation and depression (which are known be associated with cognitive decline and dementia). Conversely, it is possible that cognitive decline has an impact on sensory function (for example, affecting attention and listening skills). Currently, there is no good evidence to show that hearing loss causes dementia

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

94. Chronic heart failure in adults: diagnosis and management

on the roles of the MDT and collaboration between the MDT and the primary care team. The 2013 cardiovascular disease outcomes strategy also noted that the proportion of people with heart failure who have cardiac rehabilitation was around 4%, and that increasing this proportion would reduce mortality and hospitalisation. This update recommends that all people with heart failure are offered an easily accessible, exercise-based cardiac rehabilitation programme, if this is suitable for them. More information T (...) Cardiac rehabilitation 21 1.10 Palliative care 21 T erms used in this guideline 22 Putting this guideline into practice 23 Context 25 Key facts and figures 25 Current practice 25 More information 25 Recommendations for research 26 1 Diuretic therapy for managing fluid overload in people with advanced heart failure in the community . 26 2 Cardiac MRI versus other imaging techniques for diagnosing heart failure 26 3 The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

96. Canadian guideline for Parkinson disease

a trial of dopamine replacement therapy to help with diagnosis. n Impulse control disorders can develop on dopami- nergic therapy at any stage in the disease but are more common in patients on dopamine agonists. n Deep brain stimulation and gel infusion are now routinely used to manage motor symptoms. n Rehabilitation therapists experienced with Parkinson disease can help newly diagnosed patients, and others through all stages. VISUAL SUMMARY OF RECOMMENDATIONS FROM THE CANADIAN GUIDELINE (...) with diagnosis. n Impulse control disorders can develop on dopami- nergic therapy at any stage in the disease but are more common in patients on dopamine agonists. n Deep brain stimulation and gel infusion are now routinely used to manage motor symptoms. n Rehabilitation therapists experienced with Parkinson disease can help newly diagnosed patients, and others through all stages. VISUAL SUMMARY OF RECOMMENDATIONS FROM THE CANADIAN GUIDELINE FOR PARKINSON DISEASE, 2ND ED PARKINSON DISEASE Parkinson-visual-9

2019 CPG Infobase

97. Guidelines on Supraventricular Tachycardia (for the management of patients with) (Full text)

and complications rates of catheter ablation for supraventricular tachycardia 23 Table 12 Classification of atrioventricular nodal re-entrant tachycardia types 30 Table 13 Recommendations for sports participation in athletes with ventricular pre-excitation and supraventricular arrhythmias 46 Table 14 European Working Group 2013 report on driving and cardiovascular disease: driving in arrhythmias and conduction disorders: supraventricular tachycardia 47 List of figures Figure 1 Differential diagnosis of narrow (...) Epidemiological studies on the SVT population are limited. In the general population, the SVT prevalence is 2.25/1000 persons and the incidence is 35/100 000 person-years. Women have a risk of developing SVT that is two times greater than that of men, and persons aged ≥65 years or have more than five times the risk of developing SVT than younger individuals. Patients with lone paroxysmal SVT vs. those with cardiovascular disease are younger, have a faster SVT rate, have an earlier onset of symptoms

2019 European Society of Cardiology

98. Management of Dyslipidaemias (Full text)

Management of Dyslipidaemias 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) François Mach Chairperson Switzerland Corresponding authors: François Mach, Cardiology Department, Geneva University Hospital, 4 Gabrielle-Perret-Gentil, 1211 Geneva

2019 European Society of Cardiology

99. Diagnosis and Management of Acute Pulmonary Embolism (Full text)

considerations 3.1 Epidemiology Venous thromboembolism (VTE), clinically presenting as DVT or PE, is globally the third most frequent acute cardiovascular syndrome behind myocardial infarction and stroke. In epidemiological studies, annual incidence rates for PE range from 39–115 per 100 000 population; for DVT, incidence rates range from 53–162 per 100 000 population. , Cross-sectional data show that the incidence of VTE is almost eight times higher in individuals aged ≥80 years than in the fifth decade (...) to come. PE may cause ≤300 000 deaths per year in the US, ranking high among the causes of cardiovascular mortality. In six European countries with a total population of 454.4 million, more than 370 000 deaths were related to VTE in 2004, as estimated on the basis of an epidemiological model. Of these patients, 34% died suddenly or within a few hours of the acute event, before therapy could be initiated or take effect. Of the other patients, death resulted from acute PE that was diagnosed after death

2019 European Society of Cardiology

100. Guidelines on Chronic Coronary Syndromes (Full text)

test 18 3.1.5.6 Invasive testing 19 3.1.6 Step 6: assess event risk 21 3.1.6.1 Definition of levels of risk 22 3.2 Lifestyle management 23 3.2.1 General management of patients with coronary artery disease 23 3.2.2 Lifestyle modification and control of risk factors 23 3.2.2.1 Smoking 23 3.2.2.2 Diet and alcohol 24 3.2.2.3 Weight management 24 3.2.2.4 Physical activity 24 3.2.2.5 Cardiac rehabilitation 24 3.2.2.6 Psychosocial factors 24 3.2.2.7 Environmental factors 25 3.2.2.8 Sexual activity 25 (...) revascularization 38 5.2 Patients >1 year after initial diagnosis or revascularization 38 6. Angina without obstructive disease in the epicardial coronary arteries 40 6.1 Microvascular angina 41 6.1.1 Risk stratification 41 6.1.2 Diagnosis 41 6.1.3 Treatment 41 6.2 Vasospastic angina 42 6.2.1 Diagnosis 42 6.2.2 Treatment 42 7. Screening for coronary artery disease in asymptomatic subjects 43 8. Chronic coronary syndromes in specific circumstances 44 8.1 Cardiovascular comorbidities 44 8.1.1 Hypertension 44

2019 European Society of Cardiology

Guidelines

Guidelines – filter by country